Page 1

Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31 , 2022 [ IFRS ] Company Name : Stock Exchange Listings : Security Code Number : Representative : Contact : Telephone : Filing Date of Quarterly Financial Report : Starting Date of Dividend Payments : Preparation of Supplementary Financial Data for Quarterly Financial Results : Information Meeting for Quarterly Financial Results to be held : SUMITOMO DAINIPPON PHARMA CO . , LTD . Tokyo 4506 ( URL https://www.ds-pharma.com/ ) FASE MEMBERSHIP July 29 , 2021 Hiroshi Nomura , Representative Director , President and Chief Executive Officer Atsuko Higuchi , Executive Officer , Corporate Communications 03-5159-3300 August 5 , 2021 Yes Yes ( for institutional investors and analysts ) ( Note : All amounts are rounded to the nearest million yen ) 1. Consolidated Financial Results for the First Quarter of the Year Ending March 31 , 2022 ( April 1 , 2021 to June 30 , 2021 ) ( 1 ) Results of Operations Revenue Core operating Operating profit profit Net profit Net profit attributable to owners of the ( % represents changes from the previous year ) Total comprehensive income parent Millions of yen % Millions of yen % Millions of yen % Millions of yen % Millions of yen % Millions of yen % Three months ended 131,196 ( 2.0 ) 8,518 ( 65.0 ) 8,306 ( 64.3 ) 807 ( 94.8 ) 4,802 ( 73.7 ) ( 6,752 ) June 30 , 2021 Three months ended June 30 , 2020 133,857 13.9 24,367 9.4 23,271 ( 42.4 ) 15,566 132.2 18,259 172.4 10,279 Reference : Profit before taxes Three months ended June 30 , 2021 : ¥ 7,957 million Three months ended June 30 , 2020 : ¥ 21,979 million " Core operating profit " is calculated by deducting from operating profit any gains and losses resulting from nonrecurring factors that the Group designates ( hereinafter referred to as " Non - recurring Items " ) Three months ended June 30 , 2021 Three months ended June 30 , 2020 ( 2 ) Financial Position Basic earnings per share Yen 12.09 45.96 Earnings per share ( diluted ) Yen Total assets Net assets Equity attributable to owners of the parent As of June 30 , 2021 As of March 31 , 2021 Millions of yen 1,276,708 1,308,127 Millions of yen 638,694 648,178 Millions of yen Ratio of equity attributable to owners of the parent to total assets % Equity attributable to owners of the parent per share Yen 574,042 45.0 1,444.88 580,570 44.4 1,461.31